Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer

Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer Publisher

Ashrafizadeh M¹ ; Bakhoda MR² ; Bahmanpour Z³ ; Ilkhani K³ ; Zarrabi A⁴ ; Makvandi P^{5, 6} ; Khan H⁷ ; Mazaheri S⁸ ; Darvish M⁹ ; Mirzaei H¹⁰

Show Affiliations

1. Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran
2. Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran
3. Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4. Sabanci University, Nanotechnology Research and Application Center (SUNUM), Istanbul, Turkey
5. Centre for Micro-BioRobotics, Istituto Italiano di Tecnologia, Pisa, Italy
6. Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran
7. Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan
8. Department of Analytical Chemistry, Faculty of Chemistry, University of Kashan, Kashan, Iran
9. Department of Medical Biotechnology, Faculty of Medicine, Arak University of Medical Science, Arak, Iran
10. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran

Source: Frontiers in Chemistry Published:2020

Abstract

Pancreatic cancer is the most lethal malignancy of the gastrointestinal tract. Due to its propensity for early local and distant spread, affected patients possess extremely poor prognosis. Currently applied treatments are not effective enough to eradicate all cancer cells, and minimize their migration. Besides, these treatments are associated with adverse effects on normal cells and organs. These therapies are not able to increase the overall survival rate of patients; hence, finding novel adjuvants or alternatives is so essential. Up to now, medicinal herbs were utilized for therapeutic goals. Herbal-based medicine, as traditional biotherapeutics, were employed for cancer treatment. Of them, apigenin, as a bioactive flavonoid that possesses numerous biological properties (e.g., anti-inflammatory and anti-oxidant effects), has shown substantial anticancer activity. It seems that apigenin is capable of suppressing the proliferation of cancer cells via the induction of cell cycle arrest and apoptosis. Besides, apigenin inhibits metastasis via down-regulation of matrix metalloproteinases and the Akt signaling pathway. In pancreatic cancer cells, apigenin sensitizes cells in chemotherapy, and affects molecular pathways such as the hypoxia inducible factor (HIF), vascular endothelial growth factor (VEGF), and glucose transporter-1 (GLUT-1). Herein, the biotherapeutic activity of apigenin and its mechanisms toward cancer cells are presented in the current review to shed some light on anti-tumor activity of apigenin in different cancers, with an emphasis on pancreatic cancer. © Copyright © 2020 Ashrafizadeh, Bakhoda, Bahmanpour, Ilkhani, Zarrabi, Makvandi, Khan, Mazaheri, Darvish and Mirzaei.

Related Docs

View other Related Docs

1. Apigenin in Cancer Therapy: Prevention of Genomic Instability and Anticancer Mechanisms, Clinical and Experimental Pharmacology and Physiology (2023)

2. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways, Mini-Reviews in Medicinal Chemistry (2023)

3. The Influence of Apigenin on Cellular Responses to Radiation: From Protection to Sensitization, BioFactors (2025)

4. Potential Therapeutic Effects of Apigenin for Colorectal Adenocarcinoma: A Systematic Review and Meta-Analysis, Cancer Medicine (2024)

5. Chemotherapeutic Effects of Apigenin in Breast Cancer: Preclinical Evidence and Molecular Mechanisms; Enhanced Bioavailability by Nanoparticles, Biotechnology Reports (2022)

6. Microrna-155 and Its Exosomal Form: Small Pieces in the Gastrointestinal Cancers Puzzle, Cell Biology and Toxicology (2024)

7. Apigenin and Its Dermatological Applications: A Comprehensive Review, Phytochemistry (2022)

8. Flavonoids Target Different Molecules of Autophagic and Metastatic Pathways in Cancer Cells, Cancer Cell International (2023)

Experts (# of related papers)

View all Related Experts

Elahe Motevaseli (3)

Azadeh Manayi (3)

Style	Citing Format
MLA	Ashrafizadeh M, et al.. "Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer." Frontiers in Chemistry, vol. 8, no. , 2020, pp. -.
APA	Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H (2020). Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Frontiers in Chemistry, 8(), -.
Chicago	Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H. "Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer." Frontiers in Chemistry 8, no. (2020): -.
Harvard	Ashrafizadeh M et al. (2020) 'Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer', Frontiers in Chemistry, 8(), pp. -.
Vancouver	Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, et al.. Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Frontiers in Chemistry. 2020;8():-.
BibTex	@article{ author = {Ashrafizadeh M and Bakhoda MR and Bahmanpour Z and Ilkhani K and Zarrabi A and Makvandi P and Khan H and Mazaheri S and Darvish M and Mirzaei H}, title = {Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer}, journal = {Frontiers in Chemistry}, volume = {8}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Ashrafizadeh M AU - Bakhoda MR AU - Bahmanpour Z AU - Ilkhani K AU - Zarrabi A AU - Makvandi P AU - Khan H AU - Mazaheri S AU - Darvish M AU - Mirzaei H TI - Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer JO - Frontiers in Chemistry VL - 8 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract